Clinical trials
Periodontal Diseases trials in Turkey (Türkiye) with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Izmir Katip Celebi University | 8 |
| Necmettin Erbakan University | 5 |
| Abant Izzet Baysal University | 4 |
| Didem OZKAL EMINOGLU | 3 |
| Medipol University | 3 |
| Biruni University | 2 |
| Gazi University | 2 |
| Inonu University | 2 |
| Istanbul Medipol University Hospital | 2 |
| Kutahya Health Sciences University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Periodontal Diseases | 63 |
| Periodontitis | 29 |
| Gingivitis | 9 |
| Inflammation | 4 |
| Alveolar Bone Loss | 3 |
| Gingival Diseases | 3 |
| Diabetes Mellitus | 2 |
| Gingival Recession | 2 |
| Periodontal Pocket | 2 |
| Arachnodactyly | 1 |
Trials
Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.